Most Recent
Court draws blood in Becton, B. Braun catheter patent case
Intellectual Property November 14, 2018 12:28 pm By Miklos Bolza

A court has delivered a loss for Germany-based B. Braun Melsungen, dismissing its allegations that US-based device manufacturer Becton Dickinson infringed three of its intravenous catheter […]

Subscribe for instant access to all Lawyerly content. Already a subscriber? Login here. Want to test drive Lawyerly? Contact us to take a free trial.
Neurim fights to amend Circadin patent amid infringement case against generics
Intellectual Property November 12, 2018 9:19 pm By Miklos Bolza

Drug maker Neurim Pharmaceuticals is battling to amend its Australian patent for the blockbuster sleeping pill Circadin over opposition from two generic pharmaceutical companies, which […]

Subscribe for instant access to all Lawyerly content. Already a subscriber? Login here. Want to test drive Lawyerly? Contact us to take a free trial.
AFT Pharma ordered to pull misleading Maxigesic ads
Competition & Consumer Protection November 9, 2018 8:44 pm By Miklos Bolza

AFT Pharmaceuticals has been ordered to pull advertisements for its painkiller Maxigesic after the Federal Court ruled in favour of rival Reckitt Benckiser, finding the […]

Subscribe for instant access to all Lawyerly content. Already a subscriber? Login here. Want to test drive Lawyerly? Contact us to take a free trial.
AMS says vaginal mesh claims don’t meet bar for class action
Product Liability November 8, 2018 2:45 pm By Cat Fredenburgh

Medical device maker AMS has told the Federal Court that claims in a class action against it over allegedly defective pelvic mesh implants did not meet […]

Subscribe for instant access to all Lawyerly content. Already a subscriber? Login here. Want to test drive Lawyerly? Contact us to take a free trial.
Otsuka defence threatened in Abilify patent case
Intellectual Property November 5, 2018 9:03 pm By Miklos Bolza

The Commonwealth of Australia is weighing a bid to strike out Otsuka Pharmaceutical’s defence as the government seeks lost subsidies after an almost seven-year long […]

Subscribe for instant access to all Lawyerly content. Already a subscriber? Login here. Want to test drive Lawyerly? Contact us to take a free trial.
Alphapharm slams Sanofi amendment delay in injunction battle
Intellectual Property November 2, 2018 10:09 pm By Miklos Bolza

Generic drug maker Alphapharm says rival Sanofi-Aventis waited to amend its injector pen patent until the heated IP battle between the two firms had commenced, […]

Subscribe for instant access to all Lawyerly content. Already a subscriber? Login here. Want to test drive Lawyerly? Contact us to take a free trial.
Judge OKs $2.5M penalty against hearing aid cos. in ACCC case
Competition & Consumer Protection November 1, 2018 9:55 pm By Christine Caulfield

A judge has approved a $2.5 million penalty against two hearing aid retailers in the consumer regulator’s case alleging the companies targeted vulnerable pensioners with […]

Subscribe for instant access to all Lawyerly content. Already a subscriber? Login here. Want to test drive Lawyerly? Contact us to take a free trial.
Generic Health wins ‘modest’ cut to Bayer’s $25M damages over Yasmin
Intellectual Property October 31, 2018 11:59 pm By Christine Caulfield

Generic Health has shaved two percent off the $25 million damages awarded pharmaceutical giant Bayer in a patent infringement case over Bayer’s blockbuster oral contraceptive, […]

Subscribe for instant access to all Lawyerly content. Already a subscriber? Login here. Want to test drive Lawyerly? Contact us to take a free trial.
Generic drug cos. win trial against Wyeth over Effexor delay
Intellectual Property October 30, 2018 3:27 pm By Cat Fredenburgh

Wyeth must pay a group of generic drug companies for the harm they suffered after the drug maker won interlocutory injunctions blocking their plans to […]

Subscribe for instant access to all Lawyerly content. Already a subscriber? Login here. Want to test drive Lawyerly? Contact us to take a free trial.
Alphapharm loses bid for docs in Sanofi injector pen patent dispute
Intellectual Property October 30, 2018 11:47 pm By Cat Fredenburgh

Generic drug maker Alphapharm has lost another bid for documents from Sanofi-Aventis in advance of a hearing on Sanofi’s interlocutory application seeking to block the […]

Subscribe for instant access to all Lawyerly content. Already a subscriber? Login here. Want to test drive Lawyerly? Contact us to take a free trial.